{"nct_id":"NCT00861419","title":"To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.","status":"COMPLETED","status_verified_date":"2017-02","start_date":"2005-12","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":null,"completion_date_type":null,"phases":["PHASE1"],"tickers":["AMGN"]}